Title : Thirty Years of Tacrolimus in Clinical Practice.

Pub. Date : 2021 Mar 1

PMID : 32541562






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 As we enter the fourth decade of tacrolimus use, newer studies utilizing of novel combinations (as with the mammalian target of rapamycin (mTOR) inhibitor, everolimus, and T-cell co-stimulation blockade with belatacept) offer potential for enhanced benefits. Tacrolimus mechanistic target of rapamycin kinase Homo sapiens